ING THINK
India: from generics giant to innovation powerhouse?
From the original
ASIA/PACIFIC: India is the most dominant generics manufacturer in the world. Given the increased importance and complexity of generics and the recent free trade deal with the EU, the sector’s outlook is bright. However, India’s push into innovation is unlikely to lead to blockbus
Related speeches
4 itemsMore from ING THINK
5 items- ING THINKMay 27, 2026
Rates Spark: Up and down with oil
- ING THINKMay 27, 2026
FX Daily: RBNZ joins the hawks
- ING THINKMay 27, 2026
The Commodities Feed: Oil falls as optimism builds over US‑Iran deal
- ING THINKMay 27, 2026
China: the next Pfizer will be Chinese
- ING THINKMay 27, 2026
China’s spectacular rise reshapes Asia’s pharma future